The receptor tyrosine kinase Tie-1 is expressed predominantly on endothelial cells where it has an essential role in blood vessel formation. Targeted disruption of the Tie-1 gene results in a lethal phenotype with severe disruption to the normal integrity of the vasculature. In an examination of Tie-1 in vivo, we observed a significant pool of the receptor present in the circulation associated with the platelet fraction. Western blotting reveals the platelet form of Tie-1 to be a protein of approximately 110 kDa, this contrasts with the 135/125-kDa doublet found in endothelial cells. Platelet activation results in increased surface expression of Tie-1. The closely related receptor tyrosine kinase Tie-2/Tek is not present in platelets. Endothelial Tie-1 undergoes metalloprotease-mediated ectodomain cleavage in response to phorbol ester and other agonists. Tie-1 cleavage leads to release of the extracellular domain and generation of a cell-associated intracellular domain with signalling capacity. The potential for cleavage was investigated in platelets. In contrast to endothelial Tie-1, phorbol ester does not stimulate truncation of the platelet receptor, suggesting these cells lack one or more components of the regulated metalloprotease system controlling Tie-1. These data demonstrate the Tie-1 receptor tyrosine kinase is present on platelets and its surface expression is regulated. Furthermore, platelet Tie-1 differs significantly from the endothelial receptor. Platelet Tie-1 has the potential to modulate endothelial function by competing for any Tie ligands and may have signalling roles important in controlling aspects of platelet behaviour.

Keywords:
Platelet, Endothelial cell, Tyrosine kinase, Angiogenesis, Signalling, Tie
1.
Merenmies J, Parida L, Henkemeyer M: Receptor tyrosine kinase signaling in vascular development. Cell Growth Differ 1997;8:3–10.
2.
Partanen J, Armstrong E, Makela TP, Korhonen J, Sandberg M, Renkonen R, Knuutila S, Huebner K, Alitalo K: A novel endothelial cell surface receptor tyrosine kinase with extracellular epidermal growth factor homology domains. Mol Cell Biol 1992;12:1698–1707.
3.
Ziegler S, Bird T, Schneringer J, Schooley K, Baum P: Molecular cloning and characterization of a novel receptor protein tyrosine kinase from human placenta. Oncogene 1993;8:663–670.
4.
Dumont DJ, Yamaguchi TP, Conlon RA, Rossant J, Breitman ML : tek, a novel tyrosine kinase gene located on mouse chromosome 4, is expressed in endothelial cells and their presumptive precursors. Oncogene 1992;7:71–80.
5.
Dumont D, Gradwohl G, Fong G, Auerbach R, Breitman M: The endothelial-specific receptor tyrosine kinase, tek, is a member of a new subfamily of receptors. Oncogene 1993;8:1293–1301.
6.
Maisonpierre P, Goldfarb M, Yancopoulos G, Gao G: Distinct rat genes with related profiles of expression define a TIE receptor tyrosine kinase family. Oncogene 1993;8:1631–1637.
7.
Runting AS, Stacker SA, Wilks AF: tie2, a putative protein tyrosine kinase from a new class of cell surface receptor. Growth Factors 1993;9:99–105.
8.
Yabkowitz R, Myer S, Yanagihara D, Brankow D, Staley T, Elliot G, Hu S, Ratzkin B: Regulation of tie receptor expression on human endothelial cells by protein kinase C-mediated release of soluble tie. Blood 1997;90:706–715.
9.
Iwama A, Hamaguchi I, Hashiyama M, Murayama Y, Yasunaga K, Suda T: Molecular cloning and characterization of mouse TIE and TEK receptor tyrosine kinase genes and their expression in hematopoietic stem cells. Biochem Biophys Res Commun 1993;195:301–309.
10.
Batard P, Sansilvestri P, Seheinecker C, Knapp W, Debili N, Vainchenker W, Buhring HJ, Monier MN, Kukk E, Partanen J, Matikainen MT, Alitalo R, Hatzfeld J, Alitalo K: The tie receptor tyrosine kinase is expressed by human hematopoietic progenitor cells and by a subset of megakaryocytic cells. Blood 1996;87:2212–2220.
11.
Armstrong E, Korhonen J, Silvennoinen O, Cleveland J, Lieberman M, Alitalo R: Expression of tie receptor tyrosine kinase in leukemia cell lines. Leukemia 1993;7:1585–1591.
12.
Kukk E, Wartiovaara U, Gunji Y, Kaukonen J, Bühring HJ, Rappold I, Matikainen MT, Vihko P, Partanen J, Palotie A, Alitalo K, Alitalo R: Analysis of tie receptor tyrosine kinase in haemopoietic progenitor and leukaemia cells. Br J Haematol 1997;98:195–203.
13.
Korhonen J, Partanen J, Armstrong E, Vaahtokari A, Elenius K, Jalkanen M, Alitalo K: Enhanced expression of the tie receptor tyrosine kinase in endothelial cells during neovascularization. Blood 1992;80:2548–2555.
14.
Korhonen J, Polvi A, Partanen J, Alitalo K: The mouse tie receptor tyrosine kinase gene: Expression during embryonic angiogenesis. Oncogene 1994;9:395–403.
15.
Hatva E, Kaipainen A, Mentula P, Jaaskelainen J, Paetau A, Haltia M, Alitalo, K: Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Am J Pathol 1995;146:368–378.
16.
Hatva E, Jaaskelainen J, Hirvonen H, Alitalo K, Haltia M: Tie endothelial cell-specific receptor tyrosine kinase is upregulated in the vasculature of arteriovenous malformations. J Neuropathol Exp Neurol 1996;55:1124–1133.
17.
Puri M, Rossant J, Alitalo K, Bernstein A, Partanen J: The receptor tyrosine kinase TIE is required for integrity and survival of vascular endothelial cells. EMBO J 1995;14:5884–5891.
18.
Partanen J, Puri M, Schwartz L, Fischer KD, Bernstein A, Rossant J: Cell autonomous functions of the receptor tyrosine kinase TIE in a late phase of angiogenic capillary growth and endothelial cell survival during murine development. Development 1996;122:3013–3021.
19.
Sato T, Tozawa Y, Deutsch U, Wolburg- Bucholz K, Fujiwara Y, Gendron-Maguire M, Gridley T, Wolburg H, Risau W, Qin Y: Distinct roles of the receptor tyrosine kinases Tie-1 and Tie-2 in blood vessel formation. Nature 1995;376:70–74.
20.
Patan S: TIE1 and TIE2 receptor tyrosine kinases inversely regulate embryonic angiogenesis by the mechanism of intussusceptive microvascular growth. Microvasc Res 1998;56:1–21.
21.
McCarthy MJ, Burrows R, Bell SC, Christie G, Bell PRF, Brindle NPJ: Potential roles of metalloprotease-mediated ectodomain cleavage in signaling by the endothelial receptor tyrosine kinase Tie-1. Lab Invest 1999;79:889–895.
22.
Yabkowitz R, Meyer S, Black T, Elliott G, Merewether LA, Yamane HK: Inflammatory cytokines and vascular endothelial growth factor stimulate the release of soluble tie receptor from human endothelial cells via metalloprotease activation. Blood 1999;93:1969–1979.
23.
Marron MB, Hughes DP, McCarthy MJ, Beaumont ER, Brindle NPJ: Tie-1 receptor tyrosine kinase endodomain interaction with SHP2: Potential signalling mechanisms and roles in angiogenesis; in Maragoudakis M (ed): Angiogenesis: From the Molecular to Integrative Pharmacology. New York, Kluwer Academic/Plenum Press, 2000, pp 35–46.
24.
Glazebrook H, Hatch T, Brindle NPJ: Regulation of insulin-like growth factor 1 expression in vascular endothelial cells by inflammatory cytokines. J Vasc Res 1998;35:143–149.
25.
Knight CJ, Panesar M, Wright C, Clarke D, Butowski PS, Patel D, Patrineli A, Fox K, Goodall AH: Altered platelet function detected by flow cytometry. Effects of coronary artery disease and age. Arterioscler Thromb Vasc Biol 1997;17:2044–2053.
26.
Fujikawa K, Presman E, Isner JM, Varticovski L: Expression of tie1 and tie2 proteins during re-endothelialization in balloon-injured rat carotid artery. J Vasc Res 1999;36:272–281.
27.
White JG, Rao GH, Estensen RD: Investigation of the release reaction in platelets exposed to phorbol myristate acetate. Am J Pathol 1974;75:301–314.
28.
Downing JR, Roussel MF, Sherr CJ: Ligand and protein kinase C downmodulate the colony-stimulating factor 1 receptor by independent mechanisms. Mol Cell Biol 1989;9:2890–2896.
29.
Cabrera N, Diaz-Rodriguez E, Becker E, Martin-Zanca D, Pandiella A: TrkA receptor ectodomain cleavage generates a tyrosine phosphorylated cell-associated fragment. J Cell Biol 1996;132:427–436.
30.
Vecchi M, Baulida J, Carpenter G: Selective cleavage of the heregulin receptor ErbB-4 by protein kinase C activation. J Biol Chem 1996;271:18989–18995.
© 2000 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.